UA95602C2
(ru)
|
2004-12-30 |
2011-08-25 |
Берингер Ингельхейм Ветмедика, Инк. |
Иммуногенная композиция цвс2 и способы приготовления такой композиции
|
US7700285B1
(en)
|
2005-12-29 |
2010-04-20 |
Boehringer Ingelheim Vetmedica, Inc. |
PCV2 immunogenic compositions and methods of producing such compositions
|
US7833707B2
(en)
|
2004-12-30 |
2010-11-16 |
Boehringer Ingelheim Vetmedica, Inc. |
Methods of overexpression and recovery of porcine circovirus type 2 ORF2
|
US8703095B2
(en)
|
2005-07-07 |
2014-04-22 |
Sanofi Pasteur S.A. |
Immuno-adjuvant emulsion
|
ES2425228T3
(es)
*
|
2005-09-09 |
2013-10-14 |
Intervet International B.V. |
Vacuna contra el PCV-2
|
CA2628424A1
(en)
|
2005-11-04 |
2007-05-10 |
Novartis Vaccines And Diagnostics S.R.L. |
Adjuvanted influenza vaccines including cytokine-inducing agents
|
US20090304742A1
(en)
|
2005-11-04 |
2009-12-10 |
Novartis Vaccines And Diagnostics Srl |
Influenza vaccines with reduced amount of emulsion adjuvant
|
PT2368572T
(pt)
|
2005-11-04 |
2020-06-16 |
Seqirus Uk Ltd |
Vacinas com adjuvante dotadas de antigénios não-virião preparados a partir de vírus da gripe cultivado em cultura celular
|
BR122015028489B1
(pt)
|
2005-12-29 |
2021-10-13 |
Boehringer Ingelheim Animal Health Usa Inc |
Vacina de combinação multivalente contra pcv2, bem como uso de uma proteína orf2 na preparação da mesma
|
EP2371385B1
(en)
|
2005-12-29 |
2015-08-19 |
Boehringer Ingelheim Vetmedica, Inc. |
Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs
|
FR2896162B1
(fr)
|
2006-01-13 |
2008-02-15 |
Sanofi Pasteur Sa |
Emulsion huile dans eau thermoreversible
|
MX2008011247A
(es)
*
|
2006-03-03 |
2008-09-11 |
Merial Ltd |
Vacuna de micoplasma hyopneumoniae.
|
AU2007231027B2
(en)
|
2006-03-24 |
2013-10-03 |
Novartis Influenza Vaccines Marburg Gmbh |
Storage of influenza vaccines without refrigeration
|
GB0614460D0
(en)
|
2006-07-20 |
2006-08-30 |
Novartis Ag |
Vaccines
|
AU2007297178B2
(en)
|
2006-09-11 |
2014-07-24 |
Novartis Ag |
Making influenza virus vaccines without using eggs
|
EP2099927A4
(en)
*
|
2006-11-22 |
2010-05-05 |
Boehringer Ingelheim Vetmed |
METHODS FOR REDUCING FLAMBEES OF DISEASES ASSOCIATED WITH PORCINIC CIRCOVIRUS
|
WO2008068631A2
(en)
|
2006-12-06 |
2008-06-12 |
Novartis Ag |
Vaccines including antigen from four strains of influenza virus
|
EP2859900A1
(en)
|
2006-12-11 |
2015-04-15 |
Boehringer Ingelheim Vetmedica, Inc. |
Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
|
CA2670836C
(en)
|
2006-12-15 |
2018-09-04 |
Boehringer Ingelheim Vetmedica, Inc. |
Treatment of pigs with pcv2 antigen
|
EP1941903A1
(en)
|
2007-01-03 |
2008-07-09 |
Boehringer Ingelheim Vetmedica Gmbh |
Prophylaxis and treatment of PRDC
|
EP1958644A1
(en)
*
|
2007-02-13 |
2008-08-20 |
Boehringer Ingelheim Vetmedica Gmbh |
Prevention and treatment of sub-clinical pcvd
|
SI2144998T1
(sl)
|
2007-04-06 |
2017-05-31 |
Takeda Vaccines, Inc. |
Postopki in sestavki za žive atenuirane viruse
|
NZ582595A
(en)
|
2007-06-27 |
2012-07-27 |
Novartis Ag |
Low-additive influenza vaccines
|
US20090017064A1
(en)
*
|
2007-07-10 |
2009-01-15 |
Wyeth |
Methods and Compositions for Immunizing Pigs Against Porcine Circovirus
|
GB0714963D0
(en)
|
2007-08-01 |
2007-09-12 |
Novartis Ag |
Compositions comprising antigens
|
US7829274B2
(en)
*
|
2007-09-04 |
2010-11-09 |
Boehringer Ingelheim Vetmedica, Inc. |
Reduction of concomitant infections in pigs by the use of PCV2 antigen
|
PT2200642E
(pt)
|
2007-10-19 |
2012-05-30 |
Novartis Ag |
Formulações de vacinas meningocócicas
|
GB0810305D0
(en)
|
2008-06-05 |
2008-07-09 |
Novartis Ag |
Influenza vaccination
|
CA2710186C
(en)
*
|
2007-12-21 |
2015-11-03 |
Pfizer Inc. |
Heat treated bacterins, and emulsion vaccines prepared from such heat treated bacterins
|
BRPI0821456A2
(pt)
*
|
2007-12-31 |
2015-06-16 |
Boehring Ingelheim Vetmedica Inc |
Partícula similar à pcv2 orf2 com inserção de aminoácido estranho
|
MX2010007815A
(es)
*
|
2008-01-23 |
2010-08-10 |
Boehringer Ingelheim Vetmed |
Composiciones inmunogenicas de mycoplasma hyopneumoniae contra pcv2 y metodos para producir composiciones de este tipo.
|
NZ587798A
(en)
|
2008-03-18 |
2013-06-28 |
Novartis Ag |
Improvements in the preparation of influenza virus vaccine antigens utilising a phosphate buffer
|
CA2732035A1
(en)
*
|
2008-07-30 |
2010-02-04 |
University Of Kentucky Research Foundation |
Equine disease model for herpesvirus neurologic disease and uses thereof
|
US20110236489A1
(en)
|
2008-09-18 |
2011-09-29 |
Novartis Ag |
Vaccine adjuvant combinations
|
MX2011005604A
(es)
|
2008-11-28 |
2011-09-01 |
Merial Ltd |
Vacuna recombinante para influenza aviar y sus usos.
|
CA2752039A1
(en)
|
2009-02-10 |
2010-08-19 |
Novartis Ag |
Influenza vaccine regimens for pandemic-associated strains
|
CN102307590A
(zh)
|
2009-02-10 |
2012-01-04 |
诺华有限公司 |
具有减少量的角鲨烯的流感疫苗
|
WO2010092477A1
(en)
|
2009-02-10 |
2010-08-19 |
Novartis Ag |
Influenza vaccines with increased amounts of h3 antigen
|
EP2403526B1
(en)
|
2009-03-06 |
2019-05-15 |
GlaxoSmithKline Biologicals SA |
Chlamydia antigens
|
EP2228054A1
(en)
*
|
2009-03-13 |
2010-09-15 |
ITALFARMACO S.p.A. |
Riluzole aqueous suspensions
|
JP5668049B2
(ja)
|
2009-03-24 |
2015-02-12 |
ノバルティス アーゲー |
髄膜炎菌h因子結合タンパク質および肺炎球菌糖結合体の組み合わせ
|
JP5830009B2
(ja)
|
2009-04-14 |
2015-12-09 |
ノバルティス アーゲー |
Staphylococcusaureusに対して免疫化するための組成物
|
AU2010251761B2
(en)
*
|
2009-05-19 |
2014-10-09 |
Bioproperties Pty Ltd |
A temperature sensitive vaccine strain of Mycoplasma hyopneumoniae and uses thereof
|
KR101800245B1
(ko)
|
2009-05-21 |
2017-11-22 |
노파르티스 아게 |
비-내인성 pol i 프로모터를 사용하는 역 유전학
|
WO2010136896A1
(en)
|
2009-05-29 |
2010-12-02 |
Novartis Ag |
Assays for influenza virus hemagglutinins
|
SG177533A1
(en)
|
2009-07-07 |
2012-02-28 |
Novartis Ag |
Conserved escherichia coli immunogens
|
SG178035A1
(en)
|
2009-07-16 |
2012-03-29 |
Novartis Ag |
Detoxified escherichia coli immunogens
|
US9085610B2
(en)
*
|
2009-07-31 |
2015-07-21 |
National Research Council Of Canada |
H. pylori lipopolysaccharide outer core epitope
|
AR078253A1
(es)
*
|
2009-09-02 |
2011-10-26 |
Boehringer Ingelheim Vetmed |
Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad
|
US20120237536A1
(en)
|
2009-09-10 |
2012-09-20 |
Novartis |
Combination vaccines against respiratory tract diseases
|
CN102573900B
(zh)
*
|
2009-09-10 |
2017-05-31 |
梅里亚股份有限公司 |
包含含有皂苷的佐剂的新疫苗制剂
|
GB0917003D0
(en)
|
2009-09-28 |
2009-11-11 |
Novartis Vaccines Inst For Global Health Srl |
Purification of bacterial vesicles
|
GB0917002D0
(en)
|
2009-09-28 |
2009-11-11 |
Novartis Vaccines Inst For Global Health Srl |
Improved shigella blebs
|
US20130022639A1
(en)
|
2009-09-30 |
2013-01-24 |
Novartis Ag |
Expression of meningococcal fhbp polypeptides
|
GB0918392D0
(en)
|
2009-10-20 |
2009-12-02 |
Novartis Ag |
Diagnostic and therapeutic methods
|
PL2491117T3
(pl)
|
2009-10-20 |
2014-05-30 |
Novartis Ag |
Udoskonalone sposoby odzyskiwania wirusa wykorzystujące odwrotną genetykę
|
GB0919690D0
(en)
|
2009-11-10 |
2009-12-23 |
Guy S And St Thomas S Nhs Foun |
compositions for immunising against staphylococcus aureus
|
US9173954B2
(en)
|
2009-12-30 |
2015-11-03 |
Glaxosmithkline Biologicals Sa |
Polysaccharide immunogens conjugated to E. coli carrier proteins
|
GB201003333D0
(en)
|
2010-02-26 |
2010-04-14 |
Novartis Ag |
Immunogenic proteins and compositions
|
JP2013522287A
(ja)
|
2010-03-18 |
2013-06-13 |
ノバルティス アーゲー |
血清群b髄膜炎菌のためのアジュバント添加ワクチン
|
FR2957933B1
(fr)
*
|
2010-03-24 |
2012-04-27 |
Seppic Sa |
Vaccin vivant pour maladies aviaires
|
GB201005625D0
(en)
|
2010-04-01 |
2010-05-19 |
Novartis Ag |
Immunogenic proteins and compositions
|
JP2013529894A
(ja)
|
2010-04-07 |
2013-07-25 |
ノバルティス アーゲー |
パルボウイルスb19のウイルス様粒子を生成するための方法
|
EP2563389B1
(en)
|
2010-04-30 |
2015-07-08 |
Temasek Life Sciences Laboratory Limited |
Universal vaccine against h5n1 lineages
|
PL2569007T3
(pl)
|
2010-05-11 |
2016-04-29 |
Intervet Int Bv |
Szczepionka przeciwko Mycoplasma Hyopneumoniae, odpowiednia do podawania w obecności przeciwciał pochodzących od matki
|
JP5876036B2
(ja)
|
2010-05-21 |
2016-03-02 |
ノバルティス アーゲー |
インフルエンザウイルス再集合方法
|
GB201009861D0
(en)
|
2010-06-11 |
2010-07-21 |
Novartis Ag |
OMV vaccines
|
US10478483B2
(en)
|
2010-06-25 |
2019-11-19 |
Glaxosmithkline Biologicals Sa |
Combinations of meningococcal factor H binding proteins
|
CA2804501C
(en)
|
2010-07-06 |
2021-01-26 |
Novartis Ag |
Noro virus derived immunogenic compositions and methods
|
GB201017519D0
(en)
|
2010-10-15 |
2010-12-01 |
Novartis Vaccines Inst For Global Health S R L |
Vaccines
|
WO2012072769A1
(en)
|
2010-12-01 |
2012-06-07 |
Novartis Ag |
Pneumococcal rrgb epitopes and clade combinations
|
BR112013022397A2
(pt)
|
2011-03-02 |
2017-09-26 |
Derek OHagan |
vacinas combinadas com doses menores de antígeno e/ou adjuvante
|
EP2736921B1
(en)
|
2011-07-25 |
2018-06-27 |
GlaxoSmithKline Biologicals SA |
Compositions and methods for assessing functional immunogenicity of parvovirus vaccines
|
TR201909110T4
(tr)
|
2011-09-14 |
2019-07-22 |
Glaxosmithkline Biologicals Sa |
Sakarit-protein glikokonjugatları yapmaya yönelik yöntemler.
|
US20140248320A1
(en)
|
2011-10-20 |
2014-09-04 |
Novartis Ag |
Adjuvanted influenza b virus vaccines for pediatric priming
|
JP2016539314A
(ja)
|
2011-12-12 |
2016-12-15 |
ノバルティス アーゲー |
インフルエンザウイルス血球凝集素のためのアッセイ法
|
EP2793939A1
(en)
|
2011-12-23 |
2014-10-29 |
Novartis AG |
Stable compositions for immunising against staphylococcus aureus
|
EP2814508B1
(en)
|
2012-02-14 |
2017-04-12 |
Merial, Inc. |
Rotavirus subunit vaccines and methods of making and use thereof
|
EP2820126B1
(en)
|
2012-03-02 |
2017-05-17 |
Seqirus UK Limited |
Influenza virus reassortment
|
JP2015526062A
(ja)
|
2012-06-04 |
2015-09-10 |
ノバルティス アーゲー |
改善された安全性試験
|
DK2890394T3
(da)
|
2012-08-31 |
2019-07-15 |
Glaxosmithkline Biologicals Sa |
Stabiliserede proteiner til immunisering mod Staphylococcus aureus
|
CN104582723A
(zh)
|
2012-08-31 |
2015-04-29 |
诺华股份有限公司 |
用于针对金黄色葡萄球菌的免疫的稳定化的蛋白质
|
HUE059179T2
(hu)
|
2012-09-10 |
2022-10-28 |
Galenbio Inc |
Vízimadárban Mycoplasma-fertõzés megelõzésére szolgáló oltóanyag
|
RU2662970C2
(ru)
|
2012-09-18 |
2018-07-31 |
Новартис Аг |
Везикулы наружной мембраны
|
CA2885625A1
(en)
|
2012-10-02 |
2014-04-10 |
Glaxosmithkline Biologicals S.A. |
Nonlinear saccharide conjugates
|
GB201218195D0
(en)
|
2012-10-10 |
2012-11-21 |
Istituto Zooprofilattico Sperimentale Delle Venezie |
Composition
|
SI2925355T1
(en)
|
2012-11-30 |
2018-04-30 |
Glaxosmithkline Biologicals S.A. |
Antigens and combinations of Pseudomonas antigens
|
BR112015012380A2
(pt)
|
2012-12-03 |
2017-09-12 |
Novartis Ag |
vírus influenza recombinante
|
AU2014229255B2
(en)
|
2013-03-13 |
2018-12-13 |
Novartis Ag |
Influenza B virus reassortment
|
EP2994162B1
(en)
|
2013-05-08 |
2021-04-07 |
Pharmgate Biologics Inc. |
Vaccine for pcv2 and mycoplasma
|
JP2016521282A
(ja)
|
2013-05-10 |
2016-07-21 |
ノバルティス アーゲー |
インフルエンザワクチンにおけるナルコレプシーのリスクの回避
|
DE202013005100U1
(de)
|
2013-06-05 |
2013-08-26 |
Novartis Ag |
Influenza Virus Reassortierung
|
DE202013005130U1
(de)
|
2013-06-05 |
2013-09-10 |
Novartis Ag |
Influenza Virus Reassortierung
|
EP3004332A2
(en)
|
2013-06-06 |
2016-04-13 |
Novartis AG |
Influenza virus reassortment
|
EA035265B1
(ru)
|
2013-10-02 |
2020-05-21 |
Бёрингер Ингельхайм Энимал Хелс Ю-Эс-Эй Инк. |
Вариант белка opc2 pcv2 и содержащие его вирусоподобные частицы
|
CA2931137C
(en)
*
|
2013-12-03 |
2023-03-14 |
Intervet International B.V. |
Vaccine against porcine circo virus type 2
|
CN103751779A
(zh)
*
|
2014-02-25 |
2014-04-30 |
中国农业科学院上海兽医研究所 |
O型***多肽的泊洛沙姆凝胶佐剂
|
MX2016012538A
(es)
|
2014-03-26 |
2016-12-14 |
Glaxosmithkline Biologicals Sa |
Antigenos estafilococicos mutantes.
|
US9713639B2
(en)
|
2014-05-19 |
2017-07-25 |
Merial, Inc. |
Recombinant spike protein subunit based vaccine for porcine epidemic diarrhea virus (PEDV)
|
US20150359880A1
(en)
*
|
2014-06-16 |
2015-12-17 |
Biomune Company |
Dual adjuvant vaccine compositions, preparation and uses
|
CN105267963A
(zh)
*
|
2014-06-18 |
2016-01-27 |
潘皓 |
纳米乳疫苗辅剂的制备方法
|
JP2015120709A
(ja)
*
|
2015-01-09 |
2015-07-02 |
ラボラトリオ アヴィメキシコ エスエー ディーイー シーヴィーLaboratorio Avi−Mex,S.A. De C.V. |
遺伝子組み換え不活性化ウィルスベクターワクチン
|
WO2016207853A2
(en)
|
2015-06-26 |
2016-12-29 |
Seqirus UK Limited |
Antigenically matched influenza vaccines
|
US10617752B2
(en)
|
2015-06-26 |
2020-04-14 |
Boehringer Ingelheim Animal Health USA Inc. |
Inactivated canine influenza vaccines and methods of making and uses thereof
|
WO2017005880A1
(en)
|
2015-07-07 |
2017-01-12 |
Seqirus UK Limited |
Influenza potency assays
|
RU2702835C1
(ru)
|
2015-10-08 |
2019-10-11 |
Мериал, Инк. |
Живая ослабленная гетерологичная вакцина от leptospira
|
DK3380119T3
(da)
|
2015-11-23 |
2021-11-15 |
Boehringer Ingelheim Animal Health Usa Inc |
Fmdv- og e2-fusionsproteiner og anvendelser deraf
|
TWI760322B
(zh)
|
2016-01-29 |
2022-04-11 |
美商百靈佳殷格翰動物保健美國有限公司 |
重組腺病毒載體裝載之fmdv疫苗及其用途
|
JOP20190088A1
(ar)
|
2016-10-21 |
2019-04-21 |
Us Agriculture |
نواقل مؤتلفة للتعبير عن مولدات مضاد فيروس انفلونزا الطيور و استخداماتها
|
WO2018099889A1
(en)
*
|
2016-11-29 |
2018-06-07 |
Intervet International B.V. |
Swine vaccine
|
CN117357642A
(zh)
|
2016-12-14 |
2024-01-09 |
勃林格殷格翰动物保健美国公司 |
表达禽病原体的多种抗原的重组hvt载体及其用途
|
FR3092754B1
(fr)
*
|
2019-02-18 |
2022-06-03 |
Total Marketing Services |
Composition adjuvante pour vaccin
|
MX2022006005A
(es)
|
2019-11-18 |
2022-10-27 |
Seqirus Pty Ltd |
Metodo para producir virus de la influenza reagrupados.
|
CN113546162B
(zh)
*
|
2021-05-31 |
2023-07-18 |
江苏省农业科学院 |
一种支原体疫苗及其制备方法
|
WO2024133656A1
(en)
|
2022-12-22 |
2024-06-27 |
Ceva Sante Animale |
Oil adjuvant compositions and vaccine emulsions comprising such oil adjuvant compositions
|